German-American medical device firm, Reprieve Cardiovascular, is eyeing up a pivotal trial with its cardiovascular drainage device after reporting success from a first-in-human study. Results from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback